ESR1 and neoplasm: A negative correlation of RBMS3 expression in the stromal cells with TNBC, and a positive one with ER- and PR-receptor status of the tumor, may indicate that there is a possibility for RBMS3 to display an antitumor effect depending on the molecular characteristics of the tumor.